Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 265

1.

Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.

Koppie TM, Grossfeld GD, Miller D, Yu J, Stier D, Broering JM, Lubeck D, Henning JM, Flanders SC, Carroll PR.

J Urol. 2000 Jul;164(1):81-8.

PMID:
10840429
2.

Watchful waiting and factors predictive of secondary treatment of localized prostate cancer.

Wu H, Sun L, Moul JW, Wu HY, McLeod DG, Amling C, Lance R, Kusuda L, Donahue T, Foley J, Chung A, Sexton W, Soderdahl D.

J Urol. 2004 Mar;171(3):1111-6.

PMID:
14767282
3.

Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSURE.

Meng MV, Elkin EP, Harlan SR, Mehta SS, Lubeck DP, Carroll PR.

J Urol. 2003 Dec;170(6 Pt 1):2279-83.

PMID:
14634396
4.

Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer.

Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2003 Jan;169(1):157-63.

PMID:
12478126
5.

Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era.

Carter CA, Donahue T, Sun L, Wu H, McLeod DG, Amling C, Lance R, Foley J, Sexton W, Kusuda L, Chung A, Soderdahl D, Jackmaan S, Moul JW.

J Clin Oncol. 2003 Nov 1;21(21):4001-8.

PMID:
14581423
6.

Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.

Harlan SR, Cooperberg MR, Elkin E, Lubeck DP, Meng M, Mehta SS, Carroll PR.

J Urol. 2003 Nov;170(5):1804-7.

7.

Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators..

Cancer. 2006 Apr 15;106(8):1708-14.

8.

Adjuvant radiotherapy in prostate cancer: predictors of prostate-specific antigen recurrence from the CaPSURE database.

Macdonald OK, D'Amico AV, Sadetsky N, Shrieve DC, Carroll PR.

Urology. 2007 Jul;70(1):106-10.

PMID:
17656218
9.

Is ethnicity an independent predictor of prostate cancer recurrence after radical prostatectomy?

Grossfeld GD, Latini DM, Downs T, Lubeck DP, Mehta SS, Carroll PR.

J Urol. 2002 Dec;168(6):2510-5.

PMID:
12441951
10.

Patterns of secondary cancer treatment for biochemical failure following radical prostatectomy: data from CaPSURE.

Mehta SS, Lubeck DP, Sadetsky N, Pasta DJ, Carroll PR.

J Urol. 2004 Jan;171(1):215-9.

PMID:
14665879
11.
12.
13.

Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE.

Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, Carroll PR.

Urology. 2002 Apr;59(4):560-5.

PMID:
11927314
14.

Prostate brachytherapy: a descriptive analysis from CaPSURE.

Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR; CaPSURE Investigators..

Brachytherapy. 2007 Apr-Jun;6(2):123-8.

PMID:
17434105
15.
16.

The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.

Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR; CaPSURE Investigators..

J Urol. 2004 Apr;171(4):1393-401. Review.

17.

Race/ethnicity and the intensity of medical monitoring under 'watchful waiting' for prostate cancer.

Shavers VL, Brown M, Klabunde CN, Potosky AL, Davis W, Moul J, Fahey A.

Med Care. 2004 Mar;42(3):239-50.

PMID:
15076823
18.
19.

Active surveillance for the management of prostate cancer in a contemporary cohort.

Dall'Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR, Meng MV, Kane CJ, Perez N, Master VA, Carroll PR.

Cancer. 2008 Jun 15;112(12):2664-70. doi: 10.1002/cncr.23502.

20.

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR; CaPSURE..

J Urol. 2003 Dec;170(6 Pt 2):S21-5; discussion S26-7. Erratum in: J Urol. 2004 Feb;171(2 Pt 1):811.

PMID:
14610406

Supplemental Content

Support Center